Additionally, the application of the MCT1 inhibitor-AZD3965 can elevate the lipid ROS levels by 52.8% and hence, ferroptosis in the liver tumor tissue, which can repress the tumor growth and prolong the average survival time of mice more than 1 month [111]. Here, SLC16A1 is linked to neoplasm.